<html>
  <head>
    <title></title>
    <!-- Licensed to: The Ideal Connection
         Document created using EDGARfilings PROfile 8.1.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; font-size: 8pt; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;">As filed with the Securities and Exchange
      Commission on February 11, 2022</div>
    <div>
      <div style="text-align: right; font-size: 8pt; font-weight: bold;">Registration No. 333-______</div>
      <div><br>
      </div>
    </div>
    <div style="text-align: center; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; font-weight: bold;">WASHINGTON, D.C.&#160;&#160;20549</div>
    <div style="text-align: center; margin-bottom: 6pt;">______________________________</div>
    <div style="text-align: center; font-weight: bold;">FORM&#160;S-8</div>
    <div style="text-align: center; margin-top: 6pt; font-weight: bold;">REGISTRATION STATEMENT UNDER</div>
    <div style="text-align: center; font-weight: bold;">THE SECURITIES ACT OF 1933</div>
    <div style="text-align: center;">______________________________</div>
    <div style="text-align: center; margin-top: 6pt; font-size: 12pt; font-weight: bold;">FLORA GROWTH CORP.</div>
    <div style="text-align: center; margin-bottom: 6pt; font-size: 8pt;">(Exact name of registrant as specified in its charter)</div>
    <div style="text-align: center; margin-bottom: 6pt; font-size: 8pt;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z09f7739050e7405f877956ee1f8de267" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 48.93%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-weight: bold;">Ontario, Canada</div>
          </td>
          <td style="width: 2.14%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 48.92%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-weight: bold;">Not Applicable</div>
          </td>
        </tr>
        <tr>
          <td style="width: 48.93%; vertical-align: top; font-size: 8pt;">
            <div style="text-align: center;">(State or other jurisdiction of </div>
            <div style="text-align: center;">incorporation or organization)</div>
          </td>
          <td style="width: 2.14%; vertical-align: bottom; font-size: 8pt;">&#160;</td>
          <td style="width: 48.92%; vertical-align: top;">
            <div style="text-align: center; font-size: 8pt;">(I.R.S. Employer Identification No.)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z448be78447af4ae3bb4df0077195a0ce" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-weight: bold;">198 Davenport Road</div>
            <div style="text-align: center; font-weight: bold;">Toronto, Ontario M5R 1J2</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; margin-bottom: 6pt; font-size: 8pt;">(Address of Principal Executive Offices) (Zip Code)</div>
    <div style="text-align: center; margin-bottom: 6pt; font-size: 8pt;"> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">Flora Growth Corp. Stock Option Plan</div>
    <div style="text-align: center; font-size: 8pt;">(Full title of the plan)</div>
    <div style="text-align: center;">______________________________</div>
    <div style="text-align: center; font-weight: bold;">CT Corporation System</div>
    <div style="text-align: center; font-weight: bold;">28 Liberty Street</div>
    <div style="text-align: center; font-weight: bold;">New York, New York 10005</div>
    <div style="text-align: center; margin-bottom: 6pt; font-size: 8pt;">&#160;(Name and address of agent for service)</div>
    <div style="text-align: center; font-weight: bold;">+1 (302) 777-0200</div>
    <div style="text-align: center; font-size: 8pt;">(Telephone number, including area code, of agent for service)</div>
    <div style="text-align: center;">______________________________</div>
    <div style="text-align: center; margin-bottom: 6pt; font-size: 8pt; font-weight: bold;">With copies to:</div>
    <div style="text-align: center; font-weight: bold;">Rebecca G. DiStefano</div>
    <div style="text-align: center; font-weight: bold;">Greenberg Traurig, P.A.</div>
    <div style="text-align: center; font-weight: bold;">401 East Las Olas Boulevard, Suite 2000</div>
    <div style="text-align: center; font-weight: bold;">Fort Lauderdale, FL 33301</div>
    <div style="text-align: center; font-weight: bold;">Tel: +1 (954) 768-8221</div>
    <div style="text-align: center; font-weight: bold;">Fax: +1 (561) 338-7099</div>
    <div style="text-align: center;">______________________________</div>
    <div style="text-align: center; font-weight: bold;">Michael Rennie</div>
    <div style="text-align: center; font-weight: bold;">Wildeboer Dellelce LLP</div>
    <div style="text-align: center; font-weight: bold;">365 Bay Street, Suite 800</div>
    <div style="text-align: center; font-weight: bold;">Toronto, Ontario M5H 2V1</div>
    <div style="text-align: center; font-weight: bold;">Tel: +1 (416) 361-4781</div>
    <div style="text-align: center; font-weight: bold;">Fax: +1 (416) 361-1790</div>
    <div style="text-align: center;">______________________________</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; font-size: 8pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging
      growth company.&#160; See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z6b64cd58a93b4032803fcf921e62548d" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div><font style="font-size: 8pt;">Large accelerated filer&#160;&#160; &#9744;</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 252pt"></font></div>
          </td>
          <td style="width: 25%; vertical-align: top;">
            <div style="font-size: 8pt;">Accelerated filer &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160; <br>
            </div>
          </td>
          <td style="width: 25%; vertical-align: top; font-size: 8pt;">&#160;&#9744;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div><font style="font-size: 8pt;">Non-accelerated filer &#160;&#160;&#160; &#9744; </font></div>
            <div><font style="font-size: 8pt;">(Do not check if a smaller reporting company)</font></div>
          </td>
          <td style="width: 25%; vertical-align: top;">
            <div style="font-size: 8pt;">Smaller reporting company<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 12pt">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; &#160;</font></div>
          </td>
          <td style="width: 25%; vertical-align: top; font-size: 8pt;">&#160;&#9746;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 25%; vertical-align: top;">
            <div style="font-size: 8pt;">Emerging growth company&#160;&#160;&#160;&#160;&#160; <br>
            </div>
          </td>
          <td style="width: 25%; vertical-align: top; font-size: 8pt;">&#160;&#9746;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 25%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 25%; vertical-align: top;" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 8pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section
      7(a)(2)(B) of the Securities Act. &#9744; </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">EXPLANATORY NOTE</div>
    <div style="text-align: justify;">This Registration Statement on Form S-8 (this &#8220;Registration Statement&#8221;) is being filed for the purpose of registering an additional total of 2,183,884 common shares, no par value per share (the &#8220;Common Shares&#8221;) of
      Flora Growth Corp., consisting of the additional amount of Common Shares issuable upon exercise of options outstanding as of the date of this Registration Statement under the Flora Growth Corp. Stock Option Plan (the &#8220;Option Plan&#8221;) as of the date of
      this Registration Statement for which a Registration Statement on Form S-8 relating to the same employee benefit plan is effective.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">On August 31, 2021, the Registrant filed the Registration Statement on Form S-8 (File No. 333-259198) with the Securities and Exchange Commission (the &#8220;Commission&#8221;) to register&#160;a total of 4,202,214 Common Shares
      issuable upon exercise of options outstanding under the Option Plan as of August 31, 2021 (the &#8220;Prior Registration Statement&#8221;). Upon the effectiveness of this Registration Statement, an aggregate of an additional 2,183,884 Common Shares shall be
      registered for issuance from time to time under the Option Plan. Pursuant to General Instruction E to Form S-8, the contents of the Prior Registration Statement are incorporated herein by reference except to the extent supplemented, amended or
      superseded by the information set forth herein. Only those items of Form S-8 containing new information not contained in the Prior Registration Statement are presented herein. </div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt; font-weight: bold;">Incorporation of Documents by Reference.</div>
    <div style="text-align: justify; margin-bottom: 12pt;">The following documents, which have been filed with the Commission by Flora Growth Corp., an Ontario, Canada corporation (the &#8220;Company&#8221; or &#8220;Flora&#8221;), are incorporated by reference herein:</div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zb17f705e4cbb489c8336dd9106a2a28e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 18pt; margin-bottom: 12pt;">(a)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="margin: 0px 0px 12pt; text-align: justify;">The Company&#8217;s Registration Statement on Form F-1 (Commission File No. 333-261123), originally filed with the Commission on November 16, 2021, and the Prospectus related thereto, dated
                November 18, 2021, filed with the Commission on November 22, 2021 pursuant to Rule 424(b) under the Securities Act of 1933, as amended (Commission File No. 333-26123), which contains audited financial statements for the Company&#8217;s fiscal
                year ended December 31, 2020 and for the period from March 13, 2019 (inception) to December 31, 2019 (excluding certain of the financial statements of the Company and its subsidiaries included therein, which are comprised of (i) the
                financial statements of Breeze Laboratory S.A.S. for the year ended December 31, 2019 (audited) compared to the year ended December 31, 2018 (unaudited), and the accompanying report of independent auditors issued with respect thereto dated
                December&#160;15, 2020, (ii) the audited financial statements of Grupo Farmaceutico Cronomed S.A.S. for the years ended December 31, 2019 and December 31, 2018, and the accompanying report of independent auditors issued with respect thereto
                dated December&#160;16, 2020, (iii) the financial statements of Kasa Wholefoods Company S.A.S. for the year ended December 31, 2019 (audited) compared to the year ended December 31, 2018 (unaudited), and the accompanying report of independent
                auditors issued with respect thereto dated December&#160;16, 2020, (iv) the unaudited pro forma condensed consolidated financial statements of the Company as of December 31, 2020, and (v) the related notes to the foregoing excluded financial
                statements).</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z0e14e3dd56f84483b2d564d025db73de" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 18pt; margin-bottom: 12pt;">(b)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="margin: 0px 0px 12pt; text-align: justify;">All other reports filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) since the end of the fiscal year covered by the
                Prospectus referred to in (a) above.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z5959c10476be44219c0011c7d1cc4b1f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 18pt; margin-bottom: 12pt;">(c)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="margin: 0px 0px 0px; text-align: justify;">The description of the Company&#8217;s Common Shares contained in the Company&#8217;s Registration Statement on Form 8-A, filed with the Commission on May 10, 2021 (Commission File No. 001-40397),
                and any amendment or report filed for the purpose of updating such description.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt;">All documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all
      securities offered hereby have been sold or which deregisters all securities then remaining unsold, including any Reports of Foreign Private Issuers on Form 6-K submitted during such period (or portion thereof) that is identified in such form as
      being incorporated by reference into this Registration Statement, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents (not including any information that is
      not deemed &#8220;filed&#8221; with the Commission, which is not incorporated by reference herein).</div>
    <div style="text-align: justify; margin-bottom: 12pt;">Any statement contained herein or in a document incorporated by reference or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this
      Registration Statement to the extent that such statement is modified or superseded by any other subsequently filed document which is incorporated or is deemed to be incorporated by reference herein. Any such statement so modified or superseded shall
      not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt; font-weight: bold;">Exhibits.</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 12%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1"><font style="font-weight: bold;">Exhibit Number</font><br>
          </td>
          <td style="width: 5%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1"><font style="font-weight: bold;">Exhibit </font><br>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;" rowspan="1">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">4.1</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1790169/000159406219000087/ex21.htm">Articles of Incorporation of Flora Growth Corp. (incorporated by reference to Exhibit 2.1 to Flora&#8217;s Offering Statement on
                Form 1-A, filed with the Commission on October 11, 2019).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">4.2</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1790169/000159406219000087/ex22.htm">Bylaws of Flora Growth Corp. (incorporated by reference to Exhibit 2.2 to Flora&#8217;s Offering Statement on Form 1-A, filed with
                the Commission on October 11, 2019).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">4.3</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1790169/000159406221000068/ex33.htm">Articles of Amendment of Flora Growth Corp. effective April 30, 2021 (incorporated by reference to Exhibit 3.3 to Flora&#8217;s
                Amendment No. 5 to Registration Statement on Form F-1/A, filed with the Commission on May 5, 2021).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">4.4</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1790169/000159406220000004/ex31.htm">Form of Regulation A, Tier 2 Common Share Purchase Warrant (incorporated by reference to Exhibit 3.1 to Flora&#8217;s Current
                Report on Form 1-U, filed with the Commission on January 23, 2020).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">4.5</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1790169/000159406221000068/ex42.htm">Form of Founder Warrant to Purchase Common Shares (incorporated by reference to Exhibit 4.2 to Flora&#8217;s Amendment No. 5 to
                Registration Statement on Form F-1/A, filed with the Commission on May 5, 2021).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">4.6</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1790169/000159406219000095/ex41.htm">Form of Regulation A, Tier 2 Subscription Agreement (incorporated by reference to Exhibit 4.1 to Flora&#8217;s Offering Statement
                on Form 1-A/A, filed with the Commission on November 22, 2019).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">4.7</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1790169/000159406220000004/ex32.htm">Regulation A, Tier 2 Warrant Indenture (incorporated by reference to Exhibit 3.2 to Flora&#8217;s Current Report on Form 1-U,
                filed with the Commission on January 23, 2020).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">4.8</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1790169/000159406221000040/ex46.htm">Boustead Securities, LLC Form of Underwriter Warrant (incorporated by reference to Exhibit 4.6 to Flora&#8217;s Amendment No. 3 to
                Registration Statement on Form F-1/A, filed with the Commission on March 22, 2021).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">4.9</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1790169/000159406219000087/ex615.htm">Shareholders&#8217; Agreement dated October 2, 2019 among Flora Growth Corp., Guillermo Andres Ramirez Martinez, Guillermo
                Ramirez Cabrales and Oscar Mauricio Franco Ulloa (incorporated by reference to Exhibit 6.15 to Flora&#8217;s Offering Statement on Form 1-A, filed with the Commission on October 11, 2019).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">4.10</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1790169/000159406219000087/ex616.htm">Flora Growth Corp. Stock Option Plan (incorporated by reference to Exhibit 6.16 to Flora&#8217;s Offering Statement on Form 1-A,
                filed with the Commission on October 11, 2019).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">4.11</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1790169/000159406219000087/ex617.htm">Form of Stock Option Agreement (incorporated by reference to Exhibit 6.17 to Flora&#8217;s Offering Statement on Form 1-A, filed
                with the Commission on October 11, 2019).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;" rowspan="1">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">4.12</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1790169/000159406221000135/ex45.htm">Form of Unit Warrant (incorporated by reference to Exhibit 4.5 to Flora&#8217;s F-1 Registration Statement filed with the
                Commission November 16, 2021).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;" rowspan="1">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">4.13</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1790169/000159406221000135/ex46.htm">Form of Underwriter Warrant (incorporated by reference to Exhibit 4.6 to Flora&#8217;s F-1 Registration Statement filed with the
                Commission November 16, 2021).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">5.1*</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">&#160;</div>
          </td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="ex51.htm">Opinion of Wildeboer Dellelce LLP regarding the legality of the Common Shares being registered.</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">23.1*</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">&#160;</div>
          </td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="ex231.htm">Consent of Davidson &amp; Company LLP, independent registered public accounting firm.</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">23.2*</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">&#160;</div>
          </td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">Consent of Wildeboer Dellelce LLP (included in Exhibit 5.1).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">24.1*</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">&#160;</div>
          </td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">Power of Attorney (included on the signature page hereto).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;" rowspan="1">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;">107*</div>
          </td>
          <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 88.73%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify;"><a href="ex107.htm">Filing Fees</a></div>
          </td>
        </tr>

    </table>
    <div style="margin-bottom: 6pt;"><br>
    </div>
    <div style="margin-bottom: 12pt;">*Filed herewith.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; margin-bottom: 6pt; font-weight: bold;">SIGNATURES</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
      for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Toronto, Province of Ontario, Canada on February 11, 2022.</div>
    <div style="margin-bottom: 6pt;">
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 38%; font-weight: bold;" colspan="2"><strong></strong>FLORA GROWTH CORP.</td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" style="width: 35%;">&#160;</td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
              </div>
            </td>
            <td valign="top" style="width: 3%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
            </td>
            <td nowrap="nowrap" valign="top" align="left" style="width: 35%; border-bottom: #000000 2px solid">/<font style="font-style: italic;">s/Luis Merchan</font><br>
            </td>
            <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td nowrap="nowrap" valign="bottom" align="left" style="width: 35%;">Name: Luis Merchan<br>
            </td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" style="width: 35%;">Title: Chief Executive Officer <br>
            </td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" style="width: 35%;">&#160;</td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>

      </table>
    </div>
    <br>
    <div style="text-align: center; margin-bottom: 6pt; font-weight: bold;">POWER OF ATTORNEY</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;"><font style="font-weight: bold;">KNOW ALL PERSONS BY THESE PRESENTS</font>, that each person whose signature appears below constitutes and appoints Luis Merchan and Lee Leiderman
      as such person&#8217;s true and lawful attorney-in-fact and agent, each with full power of substitution and resubstitution, for such person in such person&#8217;s name, place and stead, in any and all capacities, to sign any and all amendments (including
      post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and
      each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and
      confirming all that said attorneys-in-fact and agents, or any of them, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the date
      indicated.</div>
    <table cellspacing="0" cellpadding="0" id="zc7497233151941b0b8c29d39312d2e4e" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 38.38%; vertical-align: bottom; border-bottom: 2px solid black;">
            <div style="text-align: center; font-weight: bold;">Signature</div>
          </td>
          <td style="width: 44.22%; vertical-align: bottom; border-bottom: 2px solid black;">
            <div style="text-align: center; margin-left: 6.95pt; font-weight: bold;">Title</div>
          </td>
          <td style="width: 17.4%; vertical-align: bottom; border-bottom: 2px solid black;">
            <div style="text-align: center; margin-right: 2.85pt; font-weight: bold;">Date</div>
          </td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: middle;">&#160;</td>
          <td style="width: 44.22%; vertical-align: middle;">&#160;</td>
          <td style="width: 17.4%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="font-style: italic;">/s/ Luis Merchan</div>
          </td>
          <td style="width: 44.22%; vertical-align: top;">
            <div style="margin-left: 6.95pt;">Chief Executive Officer, President and Director</div>
          </td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">
            <div style="margin-right: 2.85pt;">February 11, 2022</div>
          </td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: top;">
            <div>Luis Merchan</div>
          </td>
          <td style="width: 44.22%; vertical-align: top;">
            <div>&#160; (Principal Executive Officer)</div>
          </td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: middle;">&#160;</td>
          <td style="width: 44.22%; vertical-align: top;">&#160;</td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="font-style: italic;">/s/ Lee Leiderman</div>
          </td>
          <td style="width: 44.22%; vertical-align: top;">
            <div style="margin-left: 6.95pt;">Chief Financial Officer</div>
          </td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">
            <div style="margin-right: 2.85pt;">February 11, 2022</div>
          </td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: top;">
            <div>Lee Leiderman</div>
          </td>
          <td style="width: 44.22%; vertical-align: top;">
            <div style="margin-left: 6.95pt;">(Principal Financial Officer and Principal Accounting Officer)</div>
          </td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: middle;">&#160;</td>
          <td style="width: 44.22%; vertical-align: top;">&#160;</td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="font-style: italic;">/s/ Dr. Bernard Wilson</div>
          </td>
          <td style="width: 44.22%; vertical-align: top;">
            <div style="margin-left: 6.95pt;">Chairman</div>
          </td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">
            <div style="margin-right: 2.85pt;">February 11, 2022</div>
          </td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: top;">
            <div>Dr. Bernard Wilson</div>
          </td>
          <td style="width: 44.22%; vertical-align: top;">&#160;</td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: middle;">&#160;</td>
          <td style="width: 44.22%; vertical-align: top;">&#160;</td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="font-style: italic;">/s/ Dr. Beverley Richardson</div>
          </td>
          <td style="width: 44.22%; vertical-align: top;">
            <div style="margin-left: 6.95pt;">Director</div>
          </td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">
            <div style="margin-right: 2.85pt;">February 11, 2022</div>
          </td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: top;">
            <div>Dr. Beverley Richardson</div>
          </td>
          <td style="width: 44.22%; vertical-align: top;">&#160;</td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: middle;">&#160;</td>
          <td style="width: 44.22%; vertical-align: top;">&#160;</td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="font-style: italic;">/s/ Juan Carlos Gomez Roa</div>
          </td>
          <td style="width: 44.22%; vertical-align: top;">
            <div style="margin-left: 6.95pt;">Director</div>
          </td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">
            <div style="margin-right: 2.85pt;">February 11, 2022</div>
          </td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: bottom;">
            <div>Juan Carlos Gomez Roa</div>
          </td>
          <td style="width: 44.22%; vertical-align: top;">&#160;</td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: top;">&#160;</td>
          <td style="width: 44.22%; vertical-align: top;">&#160;</td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="font-style: italic;">/s/ Annabelle Manalo-Morgan</div>
          </td>
          <td style="width: 44.22%; vertical-align: top;">
            <div style="margin-left: 6.95pt;">Director</div>
          </td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">
            <div style="margin-right: 2.85pt;">February 11, 2022</div>
          </td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: top;">
            <div>Annabelle Manalo-Morgan, PhD</div>
          </td>
          <td style="width: 44.22%; vertical-align: top;">&#160;</td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: top;">&#160;</td>
          <td style="width: 44.22%; vertical-align: top;">&#160;</td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="font-style: italic;">/s/ Marc Mastronardi</div>
          </td>
          <td style="width: 44.22%; vertical-align: top;">
            <div>&#160; Director</div>
          </td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">
            <div style="margin-right: 2.85pt;">February 11, 2022</div>
          </td>
        </tr>
        <tr>
          <td style="width: 38.38%; vertical-align: top;">
            <div>Marc Mastronardi</div>
          </td>
          <td style="width: 44.22%; vertical-align: top;">&#160;</td>
          <td style="width: 17.4%; vertical-align: bottom; text-align: center;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; font-weight: bold;">Signature of Authorized U.S. Representative of Registrant</div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 36pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Flora Growth Corp., has signed this registration
        statement on February 11, 2022.</div>
      <div><br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zabaf134bdb0541dcbe1dc2729ea10577" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 48.64%; vertical-align: top;">&#160;</td>
          <td style="width: 7%; vertical-align: top;">
            <div>By:</div>
          </td>
          <td nowrap="nowrap" style="width: 36.62%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div>/<font style="font-style: italic;">s/ Luis Merchan</font></div>
          </td>
          <td style="width: 7.74%; vertical-align: top;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 48.64%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 7%; vertical-align: top;">
            <div>Name:</div>
          </td>
          <td nowrap="nowrap" style="width: 36.62%; vertical-align: bottom;">
            <div>Luis Merchan</div>
          </td>
          <td style="width: 7.74%; vertical-align: top;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 48.64%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 7%; vertical-align: top;">
            <div>Title:</div>
          </td>
          <td style="width: 36.62%; vertical-align: top;">
            <div>Chief Executive Officer</div>
          </td>
          <td style="width: 7.74%; vertical-align: top;">
            <div>&#160;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
  </div>
  <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font></div>
</body>
</html>
[{"type": "S-8", "sequence": "1", "filename": "forms8.htm", "description": "S-8", "secsgml_size_bytes": 52205}]
{"company-data": {"conformed-name": "Flora Growth Corp.", "cik": "0001790169", "assigned-sic": "2834", "irs-number": "000000000", "state-of-incorporation": "A6", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-262660", "film-number": "22621336"}, "business-address": {"street1": "198 DAVENPORT ROAD", "city": "TORONTO", "state": "A6", "zip": "M5R 1J2", "phone": "416-861-2267"}, "mail-address": {"street1": "198 DAVENPORT ROAD", "city": "TORONTO", "state": "A6", "zip": "M5R 1J2"}}
As filed with the Securities and Exchange
      Commission on February 11, 2022
Registration No. 333-______
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
______________________________
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
______________________________
FLORA GROWTH CORP.
(Exact name of registrant as specified in its charter)
Ontario, Canada
Not Applicable
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer Identification No.)
198 Davenport Road
Toronto, Ontario M5R 1J2
(Address of Principal Executive Offices) (Zip Code)
Flora Growth Corp. Stock Option Plan
(Full title of the plan)
______________________________
CT Corporation System
28 Liberty Street
New York, New York 10005
(Name and address of agent for service)
+1 (302) 777-0200
(Telephone number, including area code, of agent for service)
______________________________
With copies to:
Rebecca G. DiStefano
Greenberg Traurig, P.A.
401 East Las Olas Boulevard, Suite 2000
Fort Lauderdale, FL 33301
Tel: +1 (954) 768-8221
Fax: +1 (561) 338-7099
______________________________
Michael Rennie
Wildeboer Dellelce LLP
365 Bay Street, Suite 800
Toronto, Ontario M5H 2V1
Tel: +1 (416) 361-4781
Fax: +1 (416) 361-1790
______________________________
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging
      growth company.  See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer   ☐
Accelerated filer
☐
Non-accelerated filer     ☐
(Do not check if a smaller reporting company)
Smaller reporting company
☒
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section
      7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
This Registration Statement on Form S-8 (this "Registration Statement") is being filed for the purpose of registering an additional total of 2,183,884 common shares, no par value per share (the "Common Shares") of
      Flora Growth Corp., consisting of the additional amount of Common Shares issuable upon exercise of options outstanding as of the date of this Registration Statement under the Flora Growth Corp. Stock Option Plan (the "Option Plan") as of the date of
      this Registration Statement for which a Registration Statement on Form S-8 relating to the same employee benefit plan is effective.
On August 31, 2021, the Registrant filed the Registration Statement on Form S-8 (File No. 333-259198) with the Securities and Exchange Commission (the "Commission") to register a total of 4,202,214 Common Shares
      issuable upon exercise of options outstanding under the Option Plan as of August 31, 2021 (the "Prior Registration Statement"). Upon the effectiveness of this Registration Statement, an aggregate of an additional 2,183,884 Common Shares shall be
      registered for issuance from time to time under the Option Plan. Pursuant to General Instruction E to Form S-8, the contents of the Prior Registration Statement are incorporated herein by reference except to the extent supplemented, amended or
      superseded by the information set forth herein. Only those items of Form S-8 containing new information not contained in the Prior Registration Statement are presented herein.
Incorporation of Documents by Reference.
The following documents, which have been filed with the Commission by Flora Growth Corp., an Ontario, Canada corporation (the "Company" or "Flora"), are incorporated by reference herein:
(a)
The Company's Registration Statement on Form F-1 (Commission File No. 333-261123), originally filed with the Commission on November 16, 2021, and the Prospectus related thereto, dated
                November 18, 2021, filed with the Commission on November 22, 2021 pursuant to Rule 424(b) under the Securities Act of 1933, as amended (Commission File No. 333-26123), which contains audited financial statements for the Company's fiscal
                year ended December 31, 2020 and for the period from March 13, 2019 (inception) to December 31, 2019 (excluding certain of the financial statements of the Company and its subsidiaries included therein, which are comprised of (i) the
                financial statements of Breeze Laboratory S.A.S. for the year ended December 31, 2019 (audited) compared to the year ended December 31, 2018 (unaudited), and the accompanying report of independent auditors issued with respect thereto dated
                December 15, 2020, (ii) the audited financial statements of Grupo Farmaceutico Cronomed S.A.S. for the years ended December 31, 2019 and December 31, 2018, and the accompanying report of independent auditors issued with respect thereto
                dated December 16, 2020, (iii) the financial statements of Kasa Wholefoods Company S.A.S. for the year ended December 31, 2019 (audited) compared to the year ended December 31, 2018 (unaudited), and the accompanying report of independent
                auditors issued with respect thereto dated December 16, 2020, (iv) the unaudited pro forma condensed consolidated financial statements of the Company as of December 31, 2020, and (v) the related notes to the foregoing excluded financial
                statements).
(b)
All other reports filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") since the end of the fiscal year covered by the
                Prospectus referred to in (a) above.
(c)
The description of the Company's Common Shares contained in the Company's Registration Statement on Form 8-A, filed with the Commission on May 10, 2021 (Commission File No. 001-40397),
                and any amendment or report filed for the purpose of updating such description.
All documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all
      securities offered hereby have been sold or which deregisters all securities then remaining unsold, including any Reports of Foreign Private Issuers on Form 6-K submitted during such period (or portion thereof) that is identified in such form as
      being incorporated by reference into this Registration Statement, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents (not including any information that is
      not deemed "filed" with the Commission, which is not incorporated by reference herein).
Any statement contained herein or in a document incorporated by reference or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this
      Registration Statement to the extent that such statement is modified or superseded by any other subsequently filed document which is incorporated or is deemed to be incorporated by reference herein. Any such statement so modified or superseded shall
      not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
2
Exhibits.
Exhibit Number
Exhibit
4.1
Articles of Incorporation of Flora Growth Corp. (incorporated by reference to Exhibit 2.1 to Flora's Offering Statement on
                Form 1-A, filed with the Commission on October 11, 2019).
4.2
Bylaws of Flora Growth Corp. (incorporated by reference to Exhibit 2.2 to Flora's Offering Statement on Form 1-A, filed with
                the Commission on October 11, 2019).
4.3
Articles of Amendment of Flora Growth Corp. effective April 30, 2021 (incorporated by reference to Exhibit 3.3 to Flora's
                Amendment No. 5 to Registration Statement on Form F-1/A, filed with the Commission on May 5, 2021).
4.4
Form of Regulation A, Tier 2 Common Share Purchase Warrant (incorporated by reference to Exhibit 3.1 to Flora's Current
                Report on Form 1-U, filed with the Commission on January 23, 2020).
4.5
Form of Founder Warrant to Purchase Common Shares (incorporated by reference to Exhibit 4.2 to Flora's Amendment No. 5 to
                Registration Statement on Form F-1/A, filed with the Commission on May 5, 2021).
4.6
Form of Regulation A, Tier 2 Subscription Agreement (incorporated by reference to Exhibit 4.1 to Flora's Offering Statement
                on Form 1-A/A, filed with the Commission on November 22, 2019).
4.7
Regulation A, Tier 2 Warrant Indenture (incorporated by reference to Exhibit 3.2 to Flora's Current Report on Form 1-U,
                filed with the Commission on January 23, 2020).
4.8
Boustead Securities, LLC Form of Underwriter Warrant (incorporated by reference to Exhibit 4.6 to Flora's Amendment No. 3 to
                Registration Statement on Form F-1/A, filed with the Commission on March 22, 2021).
4.9
Shareholders' Agreement dated October 2, 2019 among Flora Growth Corp., Guillermo Andres Ramirez Martinez, Guillermo
                Ramirez Cabrales and Oscar Mauricio Franco Ulloa (incorporated by reference to Exhibit 6.15 to Flora's Offering Statement on Form 1-A, filed with the Commission on October 11, 2019).
4.10
Flora Growth Corp. Stock Option Plan (incorporated by reference to Exhibit 6.16 to Flora's Offering Statement on Form 1-A,
                filed with the Commission on October 11, 2019).
4.11
Form of Stock Option Agreement (incorporated by reference to Exhibit 6.17 to Flora's Offering Statement on Form 1-A, filed
                with the Commission on October 11, 2019).
4.12
Form of Unit Warrant (incorporated by reference to Exhibit 4.5 to Flora's F-1 Registration Statement filed with the
                Commission November 16, 2021).
4.13
Form of Underwriter Warrant (incorporated by reference to Exhibit 4.6 to Flora's F-1 Registration Statement filed with the
                Commission November 16, 2021).
5.1*
Opinion of Wildeboer Dellelce LLP regarding the legality of the Common Shares being registered.
23.1*
Consent of Davidson & Company LLP, independent registered public accounting firm.
23.2*
Consent of Wildeboer Dellelce LLP (included in Exhibit 5.1).
24.1*
Power of Attorney (included on the signature page hereto).
107*
Filing Fees
*Filed herewith.
3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
      for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Toronto, Province of Ontario, Canada on February 11, 2022.
FLORA GROWTH CORP.
By:
/
s/Luis Merchan
Name: Luis Merchan
Title: Chief Executive Officer
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS
, that each person whose signature appears below constitutes and appoints Luis Merchan and Lee Leiderman
      as such person's true and lawful attorney-in-fact and agent, each with full power of substitution and resubstitution, for such person in such person's name, place and stead, in any and all capacities, to sign any and all amendments (including
      post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and
      each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and
      confirming all that said attorneys-in-fact and agents, or any of them, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the date
      indicated.
Signature
Title
Date
/s/ Luis Merchan
Chief Executive Officer, President and Director
February 11, 2022
Luis Merchan
(Principal Executive Officer)
/s/ Lee Leiderman
Chief Financial Officer
February 11, 2022
Lee Leiderman
(Principal Financial Officer and Principal Accounting Officer)
/s/ Dr. Bernard Wilson
Chairman
February 11, 2022
Dr. Bernard Wilson
/s/ Dr. Beverley Richardson
Director
February 11, 2022
Dr. Beverley Richardson
/s/ Juan Carlos Gomez Roa
Director
February 11, 2022
Juan Carlos Gomez Roa
/s/ Annabelle Manalo-Morgan
Director
February 11, 2022
Annabelle Manalo-Morgan, PhD
/s/ Marc Mastronardi
Director
February 11, 2022
Marc Mastronardi
Signature of Authorized U.S. Representative of Registrant
Pursuant to the requirements of the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Flora Growth Corp., has signed this registration
        statement on February 11, 2022.
By:
/
s/ Luis Merchan
Name:
Luis Merchan
Title:
Chief Executive Officer
4